NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

20-valent Pneumococcal Conjugate Vaccine Safety Study in Healthy Infants
20-valent Pneumococcal Conjugate Vaccine Safety Study in Healthy Infants

NCT04379713

CompletedPhase 3

Sponsor: Pfizer

Conditions: Pneumococcal Disease

Interventions: 20-valent pneumococcal conjugate vaccine, 13-valent pneumococcal conjugate vaccine

Countries: United States, Argentina, Canada, Chile, Czechia, Finland, Germany, Greece

This study is designed to evaluate the safety and tolerability of 20vPnC in healthy infants.

Eligibility overview

Sex: ALL

Age: 42 Days to 98 Days

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria:

* Male or female infants born at ≥34 weeks of gestation and who are 2 months of age (≥42 to ≤98 days) at the time of consent (the day of birth is considered day of life 1).
* Healthy infants determined by clinical assessment, including medical history and clinical judgment, to be eligible for the study.

Exclusion Criteria:

* Previous vaccination with any licensed or investigational pneumococcal vaccine, or planned receipt through study participation.
* Major known congenital malformation or serious chronic disorder.
Locations (97)
  • Tucson, Arizona, United States
  • Fullerton, California, United States
  • Oxnard, California, United States
  • Sacramento, California, United States
  • Ventura, California, United States
  • Westlake Village, California, United States
  • Frisco, Colorado, United States
  • Fort Myers, Florida, United States
  • Gulf Breeze, Florida, United States
  • Miami, Florida, United States
  • Naples, Florida, United States
  • North Miami Beach, Florida, United States
  • Pensacola, Florida, United States
  • Pensacola, Florida, United States
  • South Miami, Florida, United States
  • Tampa, Florida, United States
  • Ammon, Idaho, United States
  • Blackfoot, Idaho, United States
  • Idaho Falls, Idaho, United States
  • Idaho Falls, Idaho, United States
  • Idaho Falls, Idaho, United States
  • Topeka, Kansas, United States
  • Louisville, Kentucky, United States
  • Boston, Massachusetts, United States
  • East Orange, New Jersey, United States
  • The Bronx, New York, United States
  • Raleigh, North Carolina, United States
  • Statesville, North Carolina, United States
  • Winston-Salem, North Carolina, United States
  • Winston-Salem, North Carolina, United States
  • + 67 more on CT.gov